chronic prurigo
Conditions
Interventions
None listed
Sponsors
Sanofi K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -Those who submit their informed consent and agree to participate in the survey -Those who have been diagnosed with prurigo nodularis by a dermatologist (i.e., introduced by dermatologists to the questionnaire as a patient with prurigo nodularis) -Those who have visited a medical institution for prurigo nodularis within the past 6 months -Males and females who are 20 years old or older, reside in Japan, and can understand and answer the questionnaire in Japanese -The duration of prurigo nodularis is 3 months or longer from the time of the survey.
Exclusion criteria
Exclusion criteria: -Applicable to inappropriate responses
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Correlation between demographic characteristics and the following scores -Correlation between treatment for prurigo nodularis and the following scores (GQ/NRS/DLQI/SF-8/WPAI/PHQ-9 scores) | — |
Secondary
| Measure | Time frame |
|---|---|
| -Correlation between treatment satisfaction for prurigo nodularis and demographic characteristics -Correlation between treatment satisfaction for prurigo nodularis and the following each score (GQ/NRS/DLQI/SF-8/WPAI/PHQ-9 scores) | — |
Countries
Japan
Contacts
Public ContactTakuo Yoshida
Sanofi K.K. Dermatology Medical Immunology Medical Specialty Care
Outcome results
None listed